TransEnterix (NYSEMKT: TRXC), a robotic surgery company, saw its shares gain an astounding 111% in May, according to S&P Global Market Intelligence. The medical device company's stock took flight for three solid reasons last month:Image Source: Getty Images.TransEnterix might be stepping into this emerging space at almost the perfect time. The robotic surgery market, after all, is forecast to become one of the fastest-growing areas in all of healthcare over the next six years, according to a report by Allied Market Research. Continue reading